Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 2, 2013, Pages 362-374

  Zavadska, Dace ^a   Anca, Ioana ^b   Andre, Francis ^c   Bakir, Mustafa ^d   Chlibek, Roman ^e   Čižman, Milan ^f   Ivaskeviciene, Inga ^g   Mangarov, Atanas ^h   Meszner, Zsofia ⁱ   Pokorn, Marko ^f   Prymula, Roman ^e,j   Richter, Darko ^k   Salman, Nuran ^l   Šimurka, Pavol ^m   Tamm, Eda ⁿ   Tešovi, Goran ^o   Urbancikova, Ingrid ^m   Usonis, Vytautas ^g  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Consultant ^*  (Belgium)

^d UNIVERSITY OF DEFENCE   (Czech Republic)

^e UNIVERSITY OF DEFENCE   (Czech Republic)

^f UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^g VILNIUS UNIVERSITY   (Lithuania)

^h Infectious Diseases Hospital   (Bulgaria)

ⁱ National Institute of Child Health   (Hungary)

^j UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^k KBC Zagreb   (Croatia)

^l ISTANBUL UNIVERSITY   (Turkey)

^m FACULTY HOSPITAL   (Slovakia)

ⁿ TARTU UNIVERSITY HOSPITAL   (Estonia)

^o UNIVERSITY OF ZAGREB   (Croatia)

more..

Author keywords

Central Europe; CEVAG; Recommendations; TBE vaccination; Tick borne encephalitis

Indexed keywords

ENCEVI; IMMUN; TICK BORNE ENCEPHALITIS VACCINE; TICOVAC; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADULT; AGED; ARTICLE; AWARENESS; BULGARIA; CLINICAL FEATURE; CROATIA; CZECH REPUBLIC; DISEASE CONTROL; DISEASE TRANSMISSION; ENDEMIC DISEASE; ESTONIA; EUROPE; FATALITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUNGARY; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; INFECTION RISK; LATVIA; LITHUANIA; MAJOR CLINICAL STUDY; MALE; POLAND; ROMANIA; SLOVAKIA; SLOVENIA; TICK BORNE ENCEPHALITIS; TURKEY (REPUBLIC); VACCINATION; EASTERN EUROPE; ENCEPHALITIS, TICK-BORNE; EPIDEMIOLOGY; IMMUNOLOGY; PROCEDURES; UTILIZATION;

ENCEPHALITIS, TICK-BORNE; ENDEMIC DISEASES; EUROPE, EASTERN; HUMANS; VACCINATION; VIRAL VACCINES;

EID: 84874738300     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22766     Document Type: Article

References (66)

1. Kollaritsch H, Krasilnikov V, Holzmann H, Karganova G, Barrett A, Suss J, et al. Background document on vaccines and vaccination against tick-borne encephalitis. Geneva, WHO Strategic Advisory Group of Experts on Immunization. Available at: http://www. who.int/immunization/sage/6-TBE-backgr-18-Mar-net-Apr- 2011.pdf (last accessed May 2012).
2. World Health Organization (WHO). Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec 2011 86:241-56; PMID:21661276.
3. Donoso-Mantke O, Schadler R, Niedrig M. A survey on cases of tick-borne encephalitis in European countries. Euro Surveill 2008
4. Centers for Disease Control and Prevention (CDC). Tick-borne encephalitis among U.S. travelers to Europe and Asia 2000-2009. JAMA 2010; 303:2132-5.
5. Suss J. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asiaan overview. Ticks Tick Borne Dis 2011; 2:2-15; PMID:21771531; http://dx.doi.org/10.1016/j.ttbdis.2010.10.007.
6. Suss J. Tick-borne encephalitis in Europe and beyond - the epidemiological situation as of 2007. Euro Surveill 2008
7. Durmiši E, Knap N, Saksida A, Trilar T, Duh D, Avšic-Županc T. Prevalence and molecular characterization of tick-borne encephalitis virus in Ixodes ricinus ticks collected in Slovenia. Vector Borne Zoonotic Dis 2011; 11:659-64; PMID:21028962; http://dx.doi.org/10. 1089/vbz.2010.0054.
8. Knap N, Korva M, Dolinšek V, Sekirnik M, Trilar T, Avšic-Županc T. Patterns of tick-borne encephalitis virus infection in rodents in Slovenia. Vector Borne Zoonotic Dis 2012; 12:236-42; PMID:22022821; http://dx.doi.org/10.1089/vbz.2011.0728.
9. Gritsun TS, Lashkevich VA, Gould EA. Tickborne encephalitis. Antiviral Res 2003; 57:129-46; PMID:12615309; http://dx.doi.org/10.1016/S0166-3542(02) 00206-1.
10. Haglund M, Gunther G. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 2003; 21(Suppl 1):S11-8; PMID:12628810; http://dx.doi.org/10.1016/S0264-410X(02)00811-3.
11. Grgi?-Vitek M, Avšic-Županc T, Klavs I. Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis. Vaccine 2010; 28:7396-400; PMID:20854899; http://dx.doi.org/10.1016/j.vaccine.2010.09.003.
12. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet 2008; 371:1861-71; PMID:18514730; http://dx.doi.org/10.1016/S0140-6736(08)60800-4. (Pubitemid 351753031)
13. Kaiser R. Tick-borne encephalitis. Infect Dis Clin North Am 2008; 22:561-75, x; PMID:18755391; http://dx.doi.org/10.1016/j.idc.2008.03.013.
14. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis 1999; 28:882-90; PMID:10825054; http://dx.doi.org/10.1086/515195. (Pubitemid 29169431)
15. Kollaritsch H, Chmelik V, Dontsenko I, Grzeszczuk A, Kondrusik M, Usonis V, et al. The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: report from a meeting of experts convened to discuss TBE in their region. Vaccine 2011; 29:4556-64; PMID:21549781; http://dx.doi.org/10.1016/j.vaccine.2011.04.061.
16. Donoso-Mantke O, Escadafal C, Niedrig M, Pfeffer M. on behalf of the Working group for Tick-borne encephalitis virus. Tick-borned encephalitis in Europe, 2007 to 2009. Euro Surveill 2011 16:pii=19976. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19976 (last accessed May 2012).
17. Estonian Health Board. http://www.terviseamet.ee/fileadmin/dok/ Nakkushaigused/statistika/2010/Epid-ulevaade-2010.pdf (last accessed April 2012).
18. European Centre for Disease Prevention and Control (ECDC). TBE situation in individual European countries. Available at: http://ecdc.europa.eu/en/ healthtopics/spotlight/spotlight-tickborne/pages/situation-in-european- countries.aspx (last accessed April 2012).
19. Epidemiological Safety and Public Health Department of Infectology. Available at: http://www.lic.gov.lv/docs/268/2009-dok/12-09-II.pdf (last accessed March 2012).
20. Public Health Authority of the Slovak Republic. Available at: http://www.uvzsr.sk (last accessed April 2012).
21. Hristova I, Dikov I, Andonova L, Taseva E, Kalvachev N, Popal S, et al. Four cases of Tick-borne encephalitis in Bulgaria. Science Infectology Parasitology Number 1 2011:43-6.
22. Aleraj B. Infectious diseases in Croatia in 2009. Croatian Journal of Infection 2010; 30:167-75.
23. Bor?i? B, Kai? B, Gardaševi?-Mori? L. Tick-borne meningoencephalitis in Gorski Kotar-new findings. Lijec Vjesn 2001 123:163-4; PMID:11729608.
24. Bor?i? B, Kai? B, Kralj V. Some epidemiological data on TBE and Lyme borreliosis in Croatia. Zentralbl Bakteriol 1999; 289:540-7; PMID:10652720; http://dx.doi.org/10.1016/S0934-8840(99)80007-3. (Pubitemid 30047246)
25. Mileti?-Medved M, ?akovi?-Rode O, Cvetko-Krajinovi? L, Markoti? A. Tick-borne meningoencephalitis in central Posavina, Croatia: seroepidemiological survey among forest workers. Infektološki glasnik 2011
26. Miši?-Majerus Lj, Zaninovi? K, Cmrk-Kadija V, ?akovi?-Rode O. Global warming, climate change and the effect on ticks and tick borne pathogens. Infektološki glasnik 2008; 28:61-8.
27. Anic K, Soldo I, Peric Lj, Karner I, Barac B. Tickborne encephalitis in eastern Croatia. Scand Infect Dis J 1998; 30.
28. Miši?-Majerus Lj, ?akovi?-Rode O, Ruži? Sablji? E. Post-encephalitic syndrome in patients with tick-borne encephalitis. Acta Med Croatica 2009 63:269-78; PMID:20034327.
29. Beran J. Tickborne encephalitis in the Czech Republic. Euro Surveill 2004 8:pii=2493. Available at: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=2493 (last accessed October 2012).
30. Epstein E, Kutsar K. Epidemological trends of tickborne encephalitis in Estonia. EpiNorth 2009; 10:58-62.
31. Golovljova I, Vene S, Sjolander KB, Vasilenko V, Plyusnin A, Lundkvist A. Characterization of tickborne encephalitis virus from Estonia. J Med Virol 2004; 74:580-8; PMID:15484275; http://dx.doi.org/10.1002/jmv.20224. (Pubitemid 39426099)
32. Kerbo N, Donchenko I, Kutsar K, Vasilenko V. Tickborne encephalitis outbreak in Estonia linked to raw goat milk, May-June 2005. Euro Surveill 2005 10:pii=2740. Available at: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=2740 (last accessed October 2012).
33. Hungarian National Centre for Epidemiology (OEK). Epinfo -Weekly Epidemiological Information Sheet. 2011;26-27. Available at: http://www.oek.hu (last accessed July 2012).
34. Balogh Z, Ferenczi E, Szeles K, Stefanoff P, Gut W, Szomor KN, et al. Tick-borne encephalitis outbreak in Hungary due to consumption of raw goat milk. J Virol Methods 2010; 163:481-5; PMID:19836419; http://dx.doi.org/10.1016/j. jviromet.2009.10.003.
35. Caini S, Szomor K, Ferenczi E, Szekelyne Gaspar A, Csohan A, Krisztalovics K, et al. Tick-borne encephalitis transmitted by unpasteurised cow milk in western Hungary, September to October 2011. Euro Surveill 2012 17:pii=20128. Available at: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=20128 (last accessed October 2012).
36. Lucenko I, Jansone I, Velicko I, Pujate E. Tickborne encephalitis in Latvia. Euro Surveill 2004; 8:pii=2495. Available at: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=2495 (last accessed October 2012).
37. Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L. Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin Infect Dis 2002; 35:650-8; PMID:12203160; http://dx.doi.org/10.1086/342059. (Pubitemid 35024723)
38. Asokliene L. Tickborn encephalitis in Lithuania. Euro Surveill 2004
39. Infectious Diseases and AIDS Center. Available at: http://www.ulac.lt/ (last accessed April 2012).
40. European Centre for Disease Prevention and Control. Available at: http://ecdc.europa.eu/(last accessed January 2012).
41. Molnar GB, Perseca T, Feder A, Pacuraru D, Marialaki E, Cojan A. [Epidemiological assessment of morbidity and natural foci of TBE-CEE virus infection in Transylvania]. Rev Med Chir Soc Med Nat Iasi 2008; 112:471-7; PMID:19295022.
42. Epidemiological Information System. Available at: http://www.epis.sk/ (last accessed July 2012).
43. Litvova S, Orlovska K. Alimentarny prenos klieštovej encefalitidy v endemickom ohnisku na Považi. Pediatria(Bratisl) 2011 6:S 25.
44. Grgi?-Vitek M, Klavs I. High burden of tick-borne encephalitis in Slovenia-challenge for vaccination policy. Vaccine 2011; 29:5178-83; PMID:21620916; http://dx.doi.org/10.1016/j.vaccine.2011.05.033.
45. Ergunay K, Saygan MB, Aydogan S, Litzba N, Sener B, Lederer S, et al. Confirmed exposure to tickborne encephalitis virus and probable human cases of tick-borne encephalitis in Central/Northern Anatolia, Turkey. Zoonoses Public Health 2011; 58:220-7; PMID:20604912; http://dx.doi.org/10.1111/j.1863-2378. 2010.01342.x.
46. Gunes T, Poyraz O, Atas M, Alim A. Seroprevalence of tick-borne encephalitis virus (TBEV) among the residents of rural areas in Sinop, central Black-Sea region, Turkey. Mikrobiyol Bul 2010
47. Kunz C. TBE vaccination and the Austrian experience. Vaccine 2003; 21(Suppl 1):S50-5; PMID:12628814; http://dx.doi.org/10.1016/S0264-410X(02)00813- 7.
48. Balogh Z, Egyed L, Ferenczi E, Ban E, Szomor KN, Takacs M, et al. Experimental infection of goats with tick-borne encephalitis virus and the possibilities to prevent virus transmission by raw goat milk. Intervirology 2012; 55:194-200; PMID:21325791; http://dx.doi.org/10.1159/000324023.
49. Grgi?-Vitek M, Klavs I. Low coverage and predictors of vaccination uptake against tick-borne encephalitis in Slovenia. Eur J Public Health 2012; 22:182-6; PMID:21398380; http://dx.doi.org/10.1093/eurpub/ckr018.
50. WHO. International Travel and Health, Chapter 6. Available at: http://www.who.int/ith/ITH2010.pdf (last accessed February 2012).
51. Smit R. Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults. Vaccine 2012; 30:6301-6; PMID:22885012; http://dx.doi.org/10. 1016/j.vaccine.2012.07.083.
52. Latvian journal of the legislation forums. Available at: http://www.likumi.lv/(last accessed March 2012).
53. Onischenko GG, Fedorov YM, Paksina ND. Surveillance of tick-borne encephalitis and activity for its prophylactic in Russian Federation. Vopr Virusol 2007
54. Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Koska M, Bobrovsky R, et al. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years. Hum Vaccin 2009; 5:551-6; PMID:19430202; http://dx.doi.org/10.4161/hv.5.8.8571.
55. Rendi-Wagner P, Kundi M, Zent O, Banzhoff A, Jaehnig P, Stemberger R, et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 2004; 23:427-34; PMID:15530690; http://dx.doi.org/10.1016/j.vaccine.2004.07.002. (Pubitemid 39463025)
56. Andersson CR, Vene S, Insulander M, Lindquist L, Lundkvist A, Gunther G. Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine 2010; 28:2827-31; PMID:20167301; http://dx.doi.org/10.1016/j.vaccine. 2010.02.001.
57. Heinz FX, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 2007; 25:7559-67; PMID:17869389; http://dx.doi.org/10.1016/j.vaccine.2007.08.024.
58. Randolph SE. on behalf of the EDEN-TBD subproject team. Human activities predominate in determining changing incidence of tick-borne encephalitis in Europe. Euro Surveill 2010 15:pii=19606. Available at: http://www. eurosurveillance.org/ViewArticle. aspx?ArticleId=19606 (last accessed October 2012).
59. Randolph SE. To what extent has climate change contributed to the recent epidemiology of tick-borne diseases? Vet Parasitol 2010; 167:92-4; PMID:19833440; http://dx.doi.org/10.1016/j.vetpar.2009.09.011.
60. Kriz B, Benes C, Danielova V, Daniel M. Socioeconomic conditions and other anthropogenic factors influencing tick-borne encephalitis incidence in the Czech Republic. Int J Med Microbiol 2004 (Pubitemid 38962771)
61. Sumilo D, Asokliene L, Bormane A, Vasilenko V, Golovljova I, Randolph SE. Climate change cannot explain the upsurge of tick-borne encephalitis in the Baltics. PLoS One 2007; 2:e500; PMID:17551580; http://dx.doi.org/10.1371/ journal.pone.0000500.
62. Wittermann Ch, Nicolay U, Hilbert A, Schondorf I. TBE vaccines: schedule to optimize protection. Int J Med Microbiol 2008 298(Suppl.1):S301-4; http://dx.doi.org/10.1016/j.ijmm.2008.01.002.
63. Prymula R, Pollabauer EM, Pavlova BG, Low-Baselli A, Fritsch S, Angermayr R, et al. Antibody persistence after two vaccinations with either FSME-IMMUN Junior or ENCEPUR Children followed by third vaccination with FSME-IMMUN Junior. Hum Vaccin Immunother 2012; 8:736-42; PMID:22699436; http://dx.doi.org/10.4161/ hv.20058.
64. Broker M, Schondorf I. Are tick-borne encephalitis vaccines interchangeable? Expert Rev Vaccines 2006 5 461-6 PMID:16989626 http://dx.doi.org/10.1586/14760584.5.4.461. (Pubitemid 44627877)
65. Banzhoff A, Broker M, Zent O. Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas. Travel Med Infect Dis 2008; 6:331-41; PMID:18984477; http://dx.doi.org/10.1016/j.tmaid. 2008.06.011.
66. Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 2011; 29:587-619; PMID:21219187; http://dx.doi.org/10.1146/annurev-immunol-031210-101315.